Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
investing
4
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
biogen
biotech ipos
cancer
cancer drugs
cancer immunotherapy
deals
fda
medicare
national
startups
third rock ventures
venture capital
89bio
abbvie
acute myeloid leukemia
adrian krainer
alexion pharmaceuticals
alx oncology
alzheimer europe conference
alzheimer's disease
amgen
antisense oligonucleotide
astrazeneca
autoimmune diseases
bain capital
benzodiazepines
berkeley lights
blackstone group
What
research
4
×
biotech
drug
ipo
medicines
new
week
aims
alzheimer’s
annual
arrival
assessed
attention
backed
bio
cancer
cause
ceo
communities
companies
conference
days
despite
drugs
epilepsy
esmo
europe
family
genes
genetic
germany
hardest
hasn’t
hit
hosted
hottest
hunters
industry
investment
ipos
Language
unset
Current search:
investing
×
research
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
